Close Menu

NEW YORK — Bioneer said on Tuesday that it has received CE-IVD marking for its AccuPower hepatitis B virus quantitative PCR kit.

In late 2018, the South Korean company received CE-IVD marking for its AccurPower RT-PCR-based HIV-1 quantitative analysis kit, and about a year later, its AccuPower RT-PCR kit for hepatitis C was CE marked. All three kits run on the company's CE-marked ExiStation system. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.